UroGen Pharma Ltd. (URGN) Climbed 5.19% or 3.09 To Price $62.69 On Tuesday

UroGen Pharma Ltd. (URGN) climbed 5.19% or 3.09 to $62.69. It is about 78431 shares traded, which is 60.61% compare to the average total volume 129399. The market cap of URGN is $862.07 million. The year to date change is 54.24%. The 52 week price range is from $13.01 to $66.38. Price of URGN have changed -5.38% during last week. It have changed 9.98% over last month, 32.30% over last 3 months, 105.94% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for URGN is 53.62. It is -14.47% below current price. The 200-day Moving Averages for URGN is 36.61. It is -41.60% below current price. The 52-week High is 66.38. It is 5.89% from the current price. The 52-week Low is 13.01. It is -79.25% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of URGN is 2.02 on 2018-03-29. Short % to float is 1.50%. There are some statistics of URGN. It is has market cap $862.07 million. The share outstanding is 13.75 million. The average volume is 129399. The percent of top 15 Institution holding is 51.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of URGN is -49.11%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of URGN is -42.24%.


Share this post